MARCKSL1 and colorectal cancer: This result is in agreement with the findings of a previous study in which we found that MARCKSL1 was significantly different in distinguishing stage IV and stage 0-II colorectal cancer, and the expression level of MARCKSL1 in stage IV patients was significantly higher than that in stage 0-II patients (P = 0.0294).